Works matching AU Park, Keunchil

Results: 203
    1

    An open-label expanded access program of afatinib in EGFR tyrosine kinase inhibitor-naïve patients with locally advanced or metastatic non-small cell lung cancer harboring EGFR mutations.

    Published in:
    2021
    By:
    • Keunchil Park;
    • Jin-Soo Kim;
    • Joo-Hang Kim;
    • Young-Chul Kim;
    • Hoon-Gu Kim;
    • Eun Kyung Cho;
    • Jong-Youl Jin;
    • Miyoung Kim;
    • Märten, Angela;
    • Jin-Hyoung Kang;
    • Park, Keunchil;
    • Kim, Jin-Soo;
    • Kim, Joo-Hang;
    • Kim, Young-Chul;
    • Kim, Hoon-Gu;
    • Cho, Eun Kyung;
    • Jin, Jong-Youl;
    • Kim, Miyoung;
    • Kang, Jin-Hyoung
    Publication type:
    journal article
    2
    3
    4

    A Randomized, Open-Label Phase II Study Evaluating Emibetuzumab Plus Erlotinib and Emibetuzumab Monotherapy in MET Immunohistochemistry Positive NSCLC Patients with Acquired Resistance to Erlotinib.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 4, p. 300, doi. 10.1016/j.cllc.2022.03.003
    By:
    • Camidge, D. Ross;
    • Moran, Teresa;
    • Demedts, Ingel;
    • Grosch, Heidrun;
    • Mileham, Kathryn;
    • Molina, Julian;
    • Juan-Vidal, Oscar;
    • Bepler, Gerold;
    • Goldman, Jonathan W.;
    • Keunchil Park;
    • Wallin, Johan;
    • Wijayawardana, Sameera R.;
    • Xuejing Aimee Wang;
    • Wacheck, Volker;
    • Smit, Egbert
    Publication type:
    Article
    5
    6

    Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 1, p. 21, doi. 10.1016/j.cllc.2021.05.007
    By:
    • Gadgeel, Shirish;
    • Hirsch, Fred R.;
    • Kerr, Keith;
    • Barlesi, Fabrice;
    • Park, Keunchil;
    • Rittmeyer, Achim;
    • Zou, Wei;
    • Bhatia, Namrata;
    • Koeppen, Hartmut;
    • Paul, Sarah M.;
    • Shames, David;
    • Yi, Jing;
    • Matheny, Christina;
    • Ballinger, Marcus;
    • McCleland, Mark;
    • Gandara, David R.
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Phase I Study Evaluating Glesatinib (MGCD265), An Inhibitor of MET and AXL, in Patients with Non-small Cell Lung Cancer and Other Advanced Solid Tumors.

    Published in:
    Targeted Oncology, 2023, v. 18, n. 1, p. 105, doi. 10.1007/s11523-022-00931-9
    By:
    • Kollmannsberger, Christian;
    • Hurwitz, Herbert;
    • Bazhenova, Lyudmila;
    • Cho, Byoung Chul;
    • Hong, David;
    • Park, Keunchil;
    • Reckamp, Karen L.;
    • Sharma, Sunil;
    • Der-Torossian, Hirak;
    • Christensen, James G.;
    • Faltaos, Demiana;
    • Potvin, Diane;
    • Tassell, Vanessa;
    • Chao, Richard;
    • Shapiro, Geoffrey I.
    Publication type:
    Article
    16
    17
    18
    19

    First-line afatinib vs gefitinib for patients with EGFR mutation-positive NSCLC (LUX-Lung 7): impact of afatinib dose adjustment and analysis of mode of initial progression for patients who continued treatment beyond progression.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1569, doi. 10.1007/s00432-019-02862-x
    By:
    • Schuler, Martin;
    • Tan, Eng-Huat;
    • O'Byrne, Kenneth;
    • Zhang, Li;
    • Boyer, Michael;
    • Mok, Tony;
    • Hirsh, Vera;
    • Yang, James Chih-Hsin;
    • Lee, Ki Hyeong;
    • Lu, Shun;
    • Shi, Yuankai;
    • Kim, Sang-We;
    • Laskin, Janessa;
    • Kim, Dong-Wan;
    • Arvis, Catherine Dubos;
    • Kölbeck, Karl;
    • Massey, Dan;
    • Märten, Angela;
    • Paz-Ares, Luis;
    • Park, Keunchil
    Publication type:
    Article
    20
    21
    22
    23

    Phase 1b Trial of Ficlatuzumab, a Humanized Hepatocyte Growth Factor Inhibitory Monoclonal Antibody, in Combination With Gefitinib in Asian Patients With NSCLC.

    Published in:
    Clinical Pharmacology in Drug Development, 2018, v. 7, n. 5, p. 532, doi. 10.1002/cpdd.427
    By:
    • Tan, Eng‐Huat;
    • Lim, Wan‐Teck;
    • Ahn, Myung‐Ju;
    • Ng, Quan‐Sing;
    • Ahn, Jin Seok;
    • Shao‐Weng Tan, Daniel;
    • Sun, Jong‐Mu;
    • Han, May;
    • Payumo, Francis C.;
    • McKee, Krista;
    • Yin, Wei;
    • Credi, Marc;
    • Agarwal, Shefali;
    • Jac, Jaroslaw;
    • Park, Keunchil
    Publication type:
    Article
    24

    Intestinal Lymphoma: Exploration of the Prognostic Factors and the Optimal Treatment.

    Published in:
    Leukemia & Lymphoma, 2004, v. 45, n. 2, p. 339, doi. 10.1080/10428190310001593111
    By:
    • Jeeyun Lee, Michele;
    • Won Seog Kiw, Michele;
    • Kihyun Kim, Michele;
    • Young Hyeh Ko;
    • Jae Jun Kim, Michele;
    • Young Ho Kim;
    • Ho Kyung Chun, Michele;
    • Woo Yong Lee;
    • Joon Oh Park, Michele;
    • Chul Won Jung, Michele;
    • Young-Hyuck Im, Michele;
    • Mark H. Lee, Michele;
    • Won Ki Kang, Michele;
    • Keunchil Park
    Publication type:
    Article
    25
    26
    27
    28

    Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14-01).

    Published in:
    2017
    By:
    • Kim, Youjin;
    • Lee, Su Jin;
    • Lee, Ji Yun;
    • Lee, Se‐Hoon;
    • Sun, Jong‐Mu;
    • Park, Keunchil;
    • An, Ho Jung;
    • Cho, Jae Yong;
    • Kang, Eun Joo;
    • Lee, Ha‐Young;
    • Kim, Jinsoo;
    • Keam, Bhumsuk;
    • Kim, Hye Ryun;
    • Lee, Kyoung Eun;
    • Choi, Moon Young;
    • Lee, Ki Hyeong;
    • Ahn, Myung‐Ju;
    • Lee, Se-Hoon;
    • Sun, Jong-Mu;
    • Lee, Ha-Young
    Publication type:
    journal article
    29
    30

    Gefitinib versus pemetrexed as second-line treatment in patients with nonsmall cell lung cancer previously treated with platinum-based chemotherapy (KCSG-LU08-01).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 24, p. 6234, doi. 10.1002/cncr.27630
    By:
    • Sun, Jong-Mu;
    • Lee, Ki Hyeong;
    • Kim, Sang-we;
    • Lee, Dae Ho;
    • Min, Young Joo;
    • Yun, Hwan Jung;
    • Kim, Hoon Kyo;
    • Song, Hong Suk;
    • Kim, Yeul Hong;
    • Kim, Bong-Seog;
    • Hwang, In Gyu;
    • Lee, Keehyun;
    • Jo, Sook Jung;
    • Lee, Jae Won;
    • Ahn, Jin Seok;
    • Park, Keunchil;
    • Ahn, Myung-Ju
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50